EMA Prepares For Launch Of PRIME Priority Medicines Scheme
This article was originally published in SRA
Executive Summary
On March 7, the European Medicines Agency is to launch its keenly awaited PRIME (priority medicines) scheme, which is intended to support the development of medicines for patients with no treatment options or that offer a major advantage over existing drugs.